Persistent proteomic alterations in the medial prefrontal cortex with abstinence from cocaine self-administration.
- Published in:
- Proteomics - Clinical Applications, 2009, v. 3, n. 4, p. 462, doi. 10.1002/prca.200800055
- By:
- Publication type:
- Article
Works matching IS 18628346 AND DT 2009 AND VI 3 AND IP 4
Results: 13
1
2
Non-invasive biomarker sampling and analysis of the exhaled breath proteome.
- Published in:
- Proteomics - Clinical Applications, 2009, v. 3, n. 4, p. 498, doi. 10.1002/prca.200800095
- By:
- Publication type:
- Article
3
Secretome-based proteomics reveals sulindac-modulated proteins released from colon cancer cells.
- Published in:
- Proteomics - Clinical Applications, 2009, v. 3, n. 4, p. 433, doi. 10.1002/prca.200800077
- By:
- Publication type:
- Article
4
Proteomic profiling of drug actions and effects.
- Published in:
- Proteomics - Clinical Applications, 2009, v. 3, n. 4, p. 409, doi. 10.1002/prca.200990012
- By:
- Publication type:
- Article
5
Proteomics identification of differentially expressed proteins in the muscle of dysferlin myopathy patients.
- Published in:
- Proteomics - Clinical Applications, 2009, v. 3, n. 4, p. 486, doi. 10.1002/prca.200800087
- By:
- Publication type:
- Article
6
Contents: Proteomics - Clinical Applications 4/2009.
- Published in:
- Proteomics - Clinical Applications, 2009, v. 3, n. 4, p. n/a, doi. 10.1002/prca.200990015
- Publication type:
- Article
7
Identification and validation of calmodulin as a binding protein of an anti-proliferative small molecule 3,4-dihydroisoquinolinium salt.
- Published in:
- Proteomics - Clinical Applications, 2009, v. 3, n. 4, p. 423, doi. 10.1002/prca.200800060
- By:
- Publication type:
- Article
8
2-D DIGE identification of differentially expressed heterogeneous nuclear ribonucleoproteins and transcription factors during neural differentiation of human embryonic stem cells.
- Published in:
- Proteomics - Clinical Applications, 2009, v. 3, n. 4, p. 505, doi. 10.1002/prca.200800109
- By:
- Publication type:
- Article
9
In this issue: Proteomics - Clinical Applications 4/2009.
- Published in:
- Proteomics - Clinical Applications, 2009, v. 3, n. 4, p. n/a, doi. 10.1002/prca.200990014
- Publication type:
- Article
10
Tracing pathway activities with kinase inhibitors and reverse phase protein arrays.
- Published in:
- Proteomics - Clinical Applications, 2009, v. 3, n. 4, p. 412, doi. 10.1002/prca.200800070
- By:
- Publication type:
- Article
11
Proteomic profiling of yeast- and hyphal-specific responses of Candida albicans to the antifungal agent, HWY-289.
- Published in:
- Proteomics - Clinical Applications, 2009, v. 3, n. 4, p. 452, doi. 10.1002/prca.200800081
- By:
- Publication type:
- Article
12
Integrative analysis of cancer pathway progression and coherence.
- Published in:
- Proteomics - Clinical Applications, 2009, v. 3, n. 4, p. 473, doi. 10.1002/prca.200800074
- By:
- Publication type:
- Article
13
Cover Picture: Proteomics - Clinical Applications 4/2009.
- Published in:
- Proteomics - Clinical Applications, 2009, v. 3, n. 4, p. n/a, doi. 10.1002/prca.200990013
- Publication type:
- Article